165 related articles for article (PubMed ID: 11061084)
1. [A case of multidrug-resistant pulmonary tuberculosis].
Tsurutani J; Sohda H; Oka M; Kohno S
Nihon Kokyuki Gakkai Zasshi; 2000 Aug; 38(8):594-8. PubMed ID: 11061084
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
3. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
5. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
Shigeto E; Murakami I; Yokosaki Y
Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
[TBL] [Abstract][Full Text] [Related]
6. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
[TBL] [Abstract][Full Text] [Related]
7. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
8. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
9. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Singla R; Gupta S; Gupta R; Arora VK
Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
[TBL] [Abstract][Full Text] [Related]
11. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
Iwanaga T; Yokota K; Kishikawa R; Ikeda T; Tsurutani H; Hirose T; Nishima S
Kekkaku; 1997 Jan; 72(1):9-13. PubMed ID: 9038010
[TBL] [Abstract][Full Text] [Related]
12. [A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported].
Wakabayashi K; Yano S; Kobayashi K; Kadowaki T; Kimura M; Ishikawa S; Ikeda T
Kekkaku; 2010 Aug; 85(8):679-82. PubMed ID: 20845688
[TBL] [Abstract][Full Text] [Related]
13. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
14. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
15. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
16. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
[TBL] [Abstract][Full Text] [Related]
17. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
18. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
[TBL] [Abstract][Full Text] [Related]
19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
20. [Resistance and efficacy of treatment in relapse pulmonary tuberculosis].
Tu D; Zhang L; Su J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):666-8. PubMed ID: 11225030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
